Chen W S, Chen J Y, Liu J M, Lin W C, King K L, Whang-Peng J, Yang W K
Department of Surgery, Veterans General Hospital, and National Yang Ming University, Taipei, Taiwan, Republic of China.
Int J Cancer. 1997 Aug 22;74(4):470-4. doi: 10.1002/(sici)1097-0215(19970822)74:4<470::aid-ijc20>3.0.co;2-c.
Microsatellite instability (MSI) is intrinsic to most colorectal carcinomas (CRC) from patients with hereditary nonpolyposis colorectal cancer (HNPCC), reflecting germline mutations in the mismatch-repair (MMR) genes. Its occurrence and chronological sequence of development in sporadic CRC appears less well defined. To explore the time sequence in acquisition of MSI, and the role it plays during tumor progression in sporadic CRC, we compared the incidence of MSI in tissue samples from 40 Dukes'-B and 30 Dukes'-D CRC patients with liver metastases, at 4 different microsatellite loci, representing sites on the APC, DCC and p53 genes respectively as well as the D2S123 site. Among the 30 patients with hepatic metastases, MSI was found in 9 (30%) of the primary, and 13 (43.3%) of the metastatic tumors. In comparison, among the 40 Dukes'-B CRC, MSI was found in only 8 cases (20%). CRC with MSI were more frequently located in the right colon, less frequently on the left side, and seldom in the rectum. Tumor ploidy analysis shows that 46.2% of Dukes'-D primary tumors with MSI are diploid (chi2 = 4.46, p = 0.035). With a mean follow-up time of 4.2 years for the Dukes'-B CRC, there were no recurrences in the 8 patients with MSI, whilst 6 (18.8%) relapses occurred amongst the 32 patients without MSI, average time to recurrence being 15 months. In Dukes'-D CRC, mean survival time for patients with MSI was 37 months (95% CI, 24 to 51 months), for those without MSI 26 months (95% CI, 18 to 35 months), although this was not statistically significant. Our data suggest that tumor progression may involve increased genetic instability.
微卫星不稳定性(MSI)是遗传性非息肉病性结直肠癌(HNPCC)患者大多数结直肠癌(CRC)的内在特征,反映了错配修复(MMR)基因中的种系突变。其在散发性CRC中的发生情况和发展的时间顺序似乎不太明确。为了探究MSI获得的时间顺序及其在散发性CRC肿瘤进展过程中所起的作用,我们比较了40例 Dukes'-B期和30例伴有肝转移的 Dukes'-D期CRC患者组织样本在4个不同微卫星位点的MSI发生率,这4个位点分别代表APC、DCC和p53基因上的位点以及D2S123位点。在30例有肝转移的患者中,原发肿瘤有9例(30%)发现MSI,转移瘤有13例(43.3%)发现MSI。相比之下,在40例 Dukes'-B期CRC中,仅8例(20%)发现MSI。伴有MSI的CRC更常位于右半结肠,较少位于左半结肠,很少位于直肠。肿瘤倍体分析显示,46.2%伴有MSI的 Dukes'-D期原发肿瘤为二倍体(χ2 = 4.46,p = 0.035)。对 Dukes'-B期CRC患者平均随访4.2年,8例伴有MSI的患者无复发,而32例无MSI的患者中有6例(18.8%)复发,平均复发时间为15个月。在 Dukes'-D期CRC中,伴有MSI的患者平均生存时间为37个月(95%可信区间,24至51个月),无MSI的患者为26个月(95%可信区间,18至35个月),尽管这在统计学上无显著差异。我们的数据表明肿瘤进展可能涉及遗传不稳定性增加。